- Home
- CADL vs GCO Comparison
CADL vs GCO Comparison
Compare CADL & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- GCO
- Stock Information
- Founded
- CADL 1999
- GCO 1924
- Country
- CADL United States
- GCO United States
- Employees
- CADL 38
- GCO N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- GCO Clothing/Shoe/Accessory Stores
- Sector
- CADL Health Care
- GCO Consumer Discretionary
- Exchange
- CADL Nasdaq
- GCO Nasdaq
- Market Cap
- CADL 252.0M
- GCO 238.4M
- IPO Year
- CADL 2021
- GCO N/A
- Fundamental
- Price
- CADL $5.10
- GCO $22.79
- Analyst Decision
- CADL Strong Buy
- GCO Hold
- Analyst Count
- CADL 5
- GCO 2
- Target Price
- CADL $21.40
- GCO $24.50
- AVG Volume (30 Days)
- CADL 923.7K
- GCO 295.1K
- Earning Date
- CADL 08-12-2025
- GCO 06-04-2025
- Dividend Yield
- CADL N/A
- GCO N/A
- EPS Growth
- CADL N/A
- GCO N/A
- EPS
- CADL N/A
- GCO N/A
- Revenue
- CADL N/A
- GCO $2,341,438,000.00
- Revenue This Year
- CADL N/A
- GCO $2.53
- Revenue Next Year
- CADL N/A
- GCO $2.01
- P/E Ratio
- CADL N/A
- GCO N/A
- Revenue Growth
- CADL N/A
- GCO 1.85
- 52 Week Low
- CADL $3.79
- GCO $16.19
- 52 Week High
- CADL $14.60
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- CADL 44.91
- GCO 55.19
- Support Level
- CADL $4.73
- GCO $19.62
- Resistance Level
- CADL $5.07
- GCO $21.31
- Average True Range (ATR)
- CADL 0.28
- GCO 1.04
- MACD
- CADL -0.01
- GCO 0.09
- Stochastic Oscillator
- CADL 48.38
- GCO 94.70
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.